Regulators knew a popular marijuana product was causing severe health problems but failed to remove it from shelves for more than a year. This delay exposed consumers to unnecessary risks and raised serious concerns about oversight in the cannabis industry.
Health officials started receiving reports in late 2022 about users suffering from intense nausea, vomiting, and other serious symptoms after using a specific brand of marijuana edibles. Lab tests later revealed unsafe levels of an unapproved additive that had not undergone proper safety evaluations before hitting the market.
By early 2023, both state and federal regulators had gathered sufficient evidence linking the product to the illnesses. Internal memos indicate they considered issuing recalls and public warnings yet decided to continue monitoring sales and complaints instead of taking immediate action, allowing more units to reach consumers across several states.
The product was only withdrawn in mid-2024 following mounting public pressure and legal challenges from affected users. Experts believe quicker intervention would have avoided many cases of illness and stress the urgent need for stronger regulations in the expanding cannabis sector to protect public health.
0.000 SRY